Erratum to 'HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Disorders (HAND)'

Heliyon. 2017 Mar 16;3(3):e00259. doi: 10.1016/j.heliyon.2017.e00259. eCollection 2017 Mar.

¹ Institut Pasteur, Antiviral Immunity, Biotherapy and Vaccine Unit, Infection and Epidemiology Department, Paris, France.
² University of Nice, L'Archet Hospital, Department of Infectious Diseases, Nice, France.
³ University of Nice, Pasteur Hospital, Department of Neurology, Nice, France.
⁴ University of Nice, L'Archet Hospital, Immunology Laboratory Unit, Nice, France.
⁵ University of Nice, Pasteur Hospital, Department of Radiology, Nice, France.
⁶ University of Nice, L'Archet Hospital, Virology Laboratory Unit, Nice, France.
⁷ University of Nice, Department of Public Health, L'Archet Hospital, Nice, France.
⁸ University of Nice, L'Archet Hospital, Department of Infectious Diseases, Nice, France; Cannes General Hospital, Department of Internal Medicine, Cannes, France.

Abstract

[This corrects the article DOI: 10.1016/j.heliyon.2017.e00245.].